Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Head and Neck Cancer

Free Subscription Articles published in BMC Cancer Retrieve available abstracts of 380 articles: HTML format

Single Articles

October 2025
1. LIU Y, He W, Wu Q, Ji JF, et al
   Establishment of a Chinese library of patient-derived xenografts from gastrointestinal cancers.
   BMC Cancer. 2025;25:1508.
   PubMed     Abstract available
   
   
   
2. YU D, Li F, Xu L, Xia X, et al
   Efficacy of local radiotherapy in first-line treatment of recurrent or metastatic esophageal squamous cell carcinoma based on immunotherapy.
   BMC Cancer. 2025;25:1484.
   PubMed     Abstract available
   
   
   September 2025
3. ZHOU Y, Xiao M, Li J, Yang H, et al
   Enhanced prognosis prediction model in esophageal cancer via lymph node assessment post-neoadjuvant.
   BMC Cancer. 2025;25:1468.
   PubMed     Abstract available
   
   
   
4. BANDALA-JACQUES A, Saldanha IJ, D'Souza G
   Oropharyngeal cancer risk groups in the United States: a meta-analysis and SEER analysis.
   BMC Cancer. 2025;25:1441.
   PubMed     Abstract available
   
   
   
5. BOLEK H, Kayaalp M, Sahin TK, Dogan OT, et al
   Real-world treatment patterns and survival outcomes in metastatic head and neck adenoid cystic carcinoma.
   BMC Cancer. 2025;25:1451.
   PubMed     Abstract available
   
   
   
6. WEN K, Huang ZR, Liu YL, Wu WB, et al
   Predictive value of nasopharyngeal microbiota for necrosis after re-irradiation in recurrent nasopharyngeal carcinoma.
   BMC Cancer. 2025;25:1436.
   PubMed     Abstract available
   
   
   
7. YAO W, Dong S, Xu P, Zhong Z, et al
   A subgroup analysis of locally advanced nasopharyngeal carcinoma patients with small lymph nodes and large nodes using adaptive radiotherapy.
   BMC Cancer. 2025;25:1414.
   PubMed     Abstract available
   
   
   
8. MALTSEVA M, Klasen C, Wuerdemann N, Hannich M, et al
   Detection and natural history of HPV infection of oral cavity and tonsils - a systematic literature review.
   BMC Cancer. 2025;25:1405.
   PubMed     Abstract available
   
   
   August 2025
9. LIU W, Ge D, Wang T, Zhao M, et al
   Salvage involved-field versus extended-field chemoradiotherapy for postoperative lymph node metastasis in esophageal squamous cell carcinoma: a retrospective clinical study.
   BMC Cancer. 2025;25:1390.
   PubMed     Abstract available
   
   
   
10. ZHANG H, Zhang B, Jiang Q, Wu B, et al
    Radical surgery versus definitive radiotherapy in treatment of locoregional upper esophageal squamous cell carcinoma.
    BMC Cancer. 2025;25:1382.
    PubMed     Abstract available
    
    
    
11. ANGUERA G, Gallego O, Llobet M, Berga N, et al
    Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma.
    BMC Cancer. 2025;25:1374.
    PubMed     Abstract available
    
    
    
12. WU H, Shu W, Ding Y, Li Q, et al
    The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapy.
    BMC Cancer. 2025;25:1369.
    PubMed     Abstract available
    
    
    
13. JEONG HJ, Lee JS, Lee JS, Yun HJ, et al
    Anti-thyroglobulin antibody levels post-thyroidectomy and papillary thyroid carcinoma recurrence.
    BMC Cancer. 2025;25:1371.
    PubMed     Abstract available
    
    
    
14. TAN C, Li Y, Jiang C, He L, et al
    DWI-guided DP-IMRT and conventional MRI-based IMRT in head and neck squamous cell carcinoma: a comparative study.
    BMC Cancer. 2025;25:1364.
    PubMed     Abstract available
    
    
    
15. LU Z, Zhu B, Ling H, Chen X, et al
    Deep learning radiomics based on MRI for differentiating tongue cancer T - staging.
    BMC Cancer. 2025;25:1358.
    PubMed     Abstract available
    
    
    
16. YANG Q, Zhou X, Li J, Wang J, et al
    Comparative analysis and optimization of tumor regression grade assessment systems in neoadjuvant therapy for esophageal squamous cell carcinoma.
    BMC Cancer. 2025;25:1341.
    PubMed     Abstract available
    
    
    
17. MAO Y, Gao Z, Sun Y, Shao C, et al
    Four-year follow-up from the phase 2 study TD-NICE: neoadjuvant treatment of tislelizumab combined with chemotherapy in resectable esophageal squamous cell carcinoma.
    BMC Cancer. 2025;25:1328.
    PubMed     Abstract available
    
    
    
18. NAWAB F, Naeem W, Fatima S, Ali A, et al
    Exploring the mutational spectrum of key kinase genes PIK3CA, BRAF, EGFR, ALK and ROS1 in oral squamous cell carcinoma.
    BMC Cancer. 2025;25:1333.
    PubMed     Abstract available
    
    
    
19. LIU L, Liu J, Rong Y, Zhang S, et al
    Comparative study of neoadjuvant chemoradiotherapy, chemotherapy, and chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma.
    BMC Cancer. 2025;25:1320.
    PubMed     Abstract available
    
    
    
20. LIU Y, Han B
    Global, regional, and national burden trends of lip and oral cavity cancer among individuals aged 60 and above from 1990 to 2021: a systematic analysis based on the 2021 global burden of disease data.
    BMC Cancer. 2025;25:1322.
    PubMed     Abstract available
    
    
    
21. PANG F, Wu L, Qiu J, Guo Y, et al
    Machine learning models for diagnosing lymph node recurrence in postoperative PTC patients: a radiomic analysis.
    BMC Cancer. 2025;25:1308.
    PubMed     Abstract available
    
    
    
22. YUAN J, Gu J, Ding M, Jin X, et al
    Protection of parathyroid function during thyroid surgery with a complete intermediate approach: a retrospective multicenter observational study.
    BMC Cancer. 2025;25:1309.
    PubMed     Abstract available
    
    
    
23. LIN X, Liu S, Ding Y, Zhao J, et al
    Contrasting tracheal, bronchus, and lung cancer burdens and care quality: a comparative analysis of China and global trends.
    BMC Cancer. 2025;25:1298.
    PubMed     Abstract available
    
    
    
24. EMERICK C, Silva LC, Jang Y, Vargas PA, et al
    Assessing the selective impact of histone modifying drugs on adenoid cystic carcinoma cells and their stem cell counterparts.
    BMC Cancer. 2025;25:1277.
    PubMed     Abstract available
    
    
    
25. DONA MG, Paolini F, Benevolo M, Rollo F, et al
    Detection and significance of HPV16 E5-specific productive transcripts in oropharyngeal carcinoma.
    BMC Cancer. 2025;25:1274.
    PubMed     Abstract available
    
    
    
26. MCLAUGHLIN RA, McMahon D, Cluxton C, Fitzpatrick OM, et al
    Neoadjuvant chemoradiation in older Irish adult patients with oesophageal cancer: a retrospective institutional review of clinical outcomes and hematological toxicity.
    BMC Cancer. 2025;25:1280.
    PubMed     Abstract available
    
    
    
27. LIU J, Duan Y, Wang Y, Li X, et al
    Novel prediction nomogram model for recurrent/persistent disease versus the American thyroid association recurrence risk stratification in patients with N1b papillary thyroid cancer: a retrospective cohort study.
    BMC Cancer. 2025;25:1271.
    PubMed     Abstract available
    
    
    
28. GUO LF, Yu YF, Lu ZZ, Lin Q, et al
    Two or three cycles of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma?
    BMC Cancer. 2025;25:1268.
    PubMed     Abstract available
    
    
    
29. CHEN J, Miao C, Wang X, Yang L, et al
    Neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma: a clinical retrospective study.
    BMC Cancer. 2025;25:1270.
    PubMed     Abstract available
    
    
    
30. LIU Q, Hu J, Liu L, He W, et al
    Development of a nomogram based on body composition and tumor burden indicators to predict lymph node metastasis in patients with T1 esophageal squamous cell carcinoma.
    BMC Cancer. 2025;25:1266.
    PubMed     Abstract available
    
    
    
31. WHANG SN, Rodarte V, Lohman T, Barforough J, et al
    30-hydroxygambogic acid increases the efficacy of cisplatin in an HPV(+) head and neck cancer in vivo model.
    BMC Cancer. 2025;25:1251.
    PubMed    
    
    
    
32. ZHONG W, Liu J, Xie J, Zhang Z, et al
    Integrative analysis of saliva-derived exosomal proteome and lipidome for the diagnosis of esophageal squamous cell carcinoma.
    BMC Cancer. 2025;25:1254.
    PubMed     Abstract available
    
    
    
33. ZHANG Q, Huang W, Chen X, Yan Z, et al
    Watch-and-wait strategy in patients with objective response after immuno-chemotherapy for locally recurrent nasopharyngeal carcinoma: a pilot study.
    BMC Cancer. 2025;25:1255.
    PubMed     Abstract available
    
    
    July 2025
34. CUI T, Chen H, Fan M, Huang W, et al
    Identifying risk factors and evaluating therapeutic interventions for anastomotic recurrence in postoperative esophageal squamous cell carcinoma.
    BMC Cancer. 2025;25:1245.
    PubMed     Abstract available
    
    
    
35. LI Y, Zhang Y, Tang R, Gu A, et al
    Clinical benefits of enhanced 3D-NEVERview sequence in MRI simulation for nasopharyngeal carcinoma patients received radiotherapy.
    BMC Cancer. 2025;25:1232.
    PubMed     Abstract available
    
    
    
36. HOESSEINI A, Dronkers EAC, Dieleman E, De Herdt MJ, et al
    Correction: Rotterdam Oncology Documentation (RONCDOC) - a high-quality data warehouse and tissue collection for head and neck cancer.
    BMC Cancer. 2025;25:1213.
    PubMed    
    
    
    
37. NING ZK, Yi H, Yang T, Liu J, et al
    Single-cell perspective on the Monocyte-to-HDL cholesterol ratio as a metastasis biomarker in papillary thyroid cancer.
    BMC Cancer. 2025;25:1203.
    PubMed     Abstract available
    
    
    
38. LI WC, Ni WQ, Zhang YL, Lin YM, et al
    Integrating pan-immune-inflammation value into personalized survival prediction of nasopharyngeal carcinoma: a large-scale long-term retrospective study.
    BMC Cancer. 2025;25:1194.
    PubMed     Abstract available
    
    
    
39. GUO D, Chen C, Zheng Y, Shan Y, et al
    Ultrasound feature-based nomogram model for predicting extrathyroidal extension in papillary thyroid carcinoma.
    BMC Cancer. 2025;25:1185.
    PubMed     Abstract available
    
    
    
40. QIN ZH, Chen SY, Zhou S, Deng H, et al
    Nasopharyngeal carcinoma detected noninvasively in the real world using three gene methylation analyses from automatically processed bilateral nasal swab samples.
    BMC Cancer. 2025;25:1147.
    PubMed     Abstract available
    
    
    
41. GUO D, Du W, Yuan J, Zhao X, et al
    Midline surpassing distance influences contralateral lymph node metastasis in cN0 tongue squamous cell carcinoma.
    BMC Cancer. 2025;25:1138.
    PubMed     Abstract available
    
    
    
42. LI K, Yang Q, Wang Y, Zhang T, et al
    Comparison of double-layered scallop-shaped anastomosis and circular stapled anastomosis in Ivor-Lewis surgery for esophageal and EGJ cancer: a retrospective cohort study.
    BMC Cancer. 2025;25:1035.
    PubMed     Abstract available
    
    
    
43. CHEN C, Wang J, Li Y
    A nomogram model to predict postoperative delirium in esophageal cancer patients undergoing esophagectomy.
    BMC Cancer. 2025;25:1082.
    PubMed     Abstract available
    
    
    
44. WANG W, Song Y, Liu S, Xiong X, et al
    Overexpression of KRAS enhanced the stemness of esophageal cancer cells inhibited by overexpression of circ0043898.
    BMC Cancer. 2025;25:1039.
    PubMed     Abstract available
    
    
    
45. FAN X, Wang S, Li W, Meng K, et al
    Assessment of intra-fractional and inter-fractional motion in esophageal cancer treated with intensity-modulated proton therapy.
    BMC Cancer. 2025;25:1112.
    PubMed     Abstract available
    
    
    
46. WU J, Qin Y, Li K, Hao W, et al
    Recurrence patterns and long-term survival of locally advanced esophageal cancer patients with pathological complete response after different neoadjuvant therapies followed by surgery.
    BMC Cancer. 2025;25:1135.
    PubMed     Abstract available
    
    
    
47. SUN HB, Feng SK, Liu XB, Xing WQ, et al
    Evaluating the efficacy of adjuvant chemotherapy in cT1b-T2 patients with incidentally discovered positive lymph nodes after esophagectomy for esophageal squamous cell carcinoma: a retrospective cohort study.
    BMC Cancer. 2025;25:1060.
    PubMed     Abstract available
    
    
    
48. LI XQ, Lin DF, Cai YC, Xie SH, et al
    Diagnostic performance of EBV DNA load testing for nasopharyngeal carcinoma in nasopharyngeal swab outperforms the approach in other specimens.
    BMC Cancer. 2025;25:1126.
    PubMed     Abstract available
    
    
    
49. JIANG QL, Wang FY, Men Y, Wu YH, et al
    Characteristic expression profile of small nucleolar RNAs and their association with tumor immune microenvironment in papillary thyroid carcinoma.
    BMC Cancer. 2025;25:1073.
    PubMed     Abstract available
    
    
    
50. SONG Z, Liu Q, Huang J, Zhang D, et al
    The value of machine learning based on spectral CT quantitative parameters in the distinguishing benign from malignant thyroid micro-nodules.
    BMC Cancer. 2025;25:1041.
    PubMed     Abstract available
    
    
    
51. CHO YB, Park KS
    Increased risk of nonalcoholic fatty liver disease in patients with thyroid cancer: a nationwide cohort study.
    BMC Cancer. 2025;25:1093.
    PubMed     Abstract available
    
    
    
52. PASVENSKAITE A, Vilkeviciute A, Duseikaite M, Pileckaite E, et al
    VEGFA (rs1570360, rs699947, rs3025033, rs2146323, rs3024997) genotypes in patients with laryngeal squamous cell carcinoma.
    BMC Cancer. 2025;25:1132.
    PubMed     Abstract available
    
    
    
53. LU CH, Yin XL, Huang ZD, Lv SA, et al
    Bioinformatics identification and validation of m6A/m1A/m5C/m7G/ac4 C-modified genes in oral squamous cell carcinoma.
    BMC Cancer. 2025;25:1055.
    PubMed     Abstract available
    
    
    
54. ZHANG K, Zhang G, Qiao Y, Zhang P, et al
    Comparison of single-port inflatable mediastinoscopic esophagectomy and thoracoscopic esophagectomy in patients with esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy.
    BMC Cancer. 2025;25:1110.
    PubMed     Abstract available
    
    
    June 2025
55. ALKA HH, Amol G, Archana S, Swati KP, et al
    Correlation of clinical presentation with prognosis in oral squamous cell carcinoma associated with oral submucous fibrosis.
    BMC Cancer. 2025;25:1000.
    PubMed     Abstract available
    
    
    
56. WU YY, Lee LC, Zeng H, Gu Y, et al
    Synergistic effects of PD-1 antibody and chemotherapy followed by surgery-centric local treatment in patients with limited-metastatic gastric or gastroesophageal adenocarcinoma (ROSETTE trial): an open-label, single-center, randomized phase 2 trial.
    BMC Cancer. 2025;25:981.
    PubMed     Abstract available
    
    
    
57. YANG X, Dou F, Tang G, Xiu R, et al
    Interpretable machine learning model for predicting anastomotic leak after esophageal cancer surgery via LightGBM.
    BMC Cancer. 2025;25:976.
    PubMed     Abstract available
    
    
    May 2025
58. YU Y, Yan J
    NAT10 inhibits the pyroptosis of laryngeal squamous cell carcinoma through ac4C modification of ELANE mRNA.
    BMC Cancer. 2025;25:970.
    PubMed     Abstract available
    
    
    
59. PAN Y, Yang H, Zhang J, Zhang R, et al
    CircSLC22A3 inhibits the invasion and metastasis of ESCC via the miR-19b-3p/TRAK2 axis and by reducing the stability of m(6)A-modified ACSBG1 mRNA.
    BMC Cancer. 2025;25:971.
    PubMed     Abstract available
    
    
    
60. XING H, Wu C, Yang W, Cai S, et al
    Tracheal, bronchus, and lung cancer among older adults: thirty-year global burden trends, precision medicine breakthroughs, and lingering barriers.
    BMC Cancer. 2025;25:954.
    PubMed     Abstract available
    
    
    
61. GONG H, Jiang T, Yang Y, Jiang Y, et al
    Short-term impact of delayed surgical treatment on the prognosis of patients with T1bN1-stage PTC: a retrospective cohort study.
    BMC Cancer. 2025;25:950.
    PubMed     Abstract available
    
    
    
62. SUN N, Liu M, Xi C, Luo Q, et al
    Comparison of efficacy and prognostic impact of adjuvant (131)I therapy at 3.7 GBq and 5.55 GBq in DTC patients with unexplained sTg elevation.
    BMC Cancer. 2025;25:912.
    PubMed     Abstract available
    
    
    
63. SPRAVE T, Sahlmann J, Thomsen AR, Klein D, et al
    Does severe mucositis impair oncological outcome in head and neck cancer patients? A pooled analysis of two prospective studies with long-term follow-up.
    BMC Cancer. 2025;25:909.
    PubMed     Abstract available
    
    
    
64. WANG W, Wang H, Liu X, Xu F, et al
    E2F2(E2F transcription factor 2) as a potential therapeutic target in meibomian gland carcinoma: evidence from functional and epigenetic studies.
    BMC Cancer. 2025;25:880.
    PubMed     Abstract available
    
    
    
65. LIU M, Liao H, Peng Q, Huang J, et al
    Comprehensive network pharmacology and experimentation to unveil the therapeutic efficacy and mechanisms of gypenoside LI in anaplastic thyroid cancer.
    BMC Cancer. 2025;25:870.
    PubMed     Abstract available
    
    
    
66. HU X, Han C, Zhang M, Jia J, et al
    Detecting radiation esophagitis using (18)F-FAPI-04 PET/CT in patients with LA-ESCC treated with concurrent chemoradiotherapy.
    BMC Cancer. 2025;25:854.
    PubMed     Abstract available
    
    
    
67. ZHAO S, Zhang Y, Meng X, Wang Y, et al
    INHBA(+) macrophages and Pro-inflammatory CAFs are associated with distinctive immunosuppressive tumor microenvironment in submucous Fibrosis-Derived oral squamous cell carcinoma.
    BMC Cancer. 2025;25:857.
    PubMed     Abstract available
    
    
    
68. WU S, Luo H, Chen W, Liu X, et al
    Camrelizumab combined with apatinib plus irinotecan as a second-line treatment in advanced or metastatic esophageal squamous cell carcinoma patients.
    BMC Cancer. 2025;25:845.
    PubMed     Abstract available
    
    
    
69. YARAHMADI HB, Shahryari K, Bozorgi M, Shirdel A, et al
    Dietary inflammatory index and the risk of esophageal cancer: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:826.
    PubMed     Abstract available
    
    
    
70. NAVRAN A, Gouw ZAR, Klop WM, Schreuder WH, et al
    Postoperative complications following salvage neck dissection after (chemo)radiotherapy for head and neck squamous cell carcinoma: which patients are at high risk?
    BMC Cancer. 2025;25:823.
    PubMed     Abstract available
    
    
    
71. CUI H, Li Z, Liu Y, Yang Y, et al
    Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the molecular feature of tumor-associated neutrophils of head and neck squamous cell carcinoma.
    BMC Cancer. 2025;25:821.
    PubMed     Abstract available
    
    
    
72. WANG Q, Li Z, Zhang J, Zhang S, et al
    Biomarkers of microvascularture by ultra Micro-angiography (UMA) assist to identify papillary thyroid carcinoma (PTC) with atypia of undetermined significance.
    BMC Cancer. 2025;25:819.
    PubMed     Abstract available
    
    
    
73. SHAN F, Wang L, Lu X, Zhou M, et al
    Integrating transcriptomic and metabolomic analyses to characterize the potential function of SLC1A5 in thyroid cancer.
    BMC Cancer. 2025;25:817.
    PubMed     Abstract available
    
    
    
74. CHEN SH, Yu BY, Kuo WY, Lin YB, et al
    Unveiling the immune microenvironment of complex tissues and tumors in transcriptomics through a deconvolution approach.
    BMC Cancer. 2025;25.
    PubMed     Abstract available
    
    
    April 2025
75. ZHANG JW, Gao XL, Wang J, Fan XL, et al
    Comprehensive analysis illustrating the role of HOXB8 in head and neck squamous cell carcinoma: evidence from multi-omics analysis and experiments validation.
    BMC Cancer. 2025;25:804.
    PubMed     Abstract available
    
    
    
76. ZHANG X, Li J, Gao M, Zhang Y, et al
    Correlation between EpCAM expression and cervical lymph node metastasis in papillary thyroid carcinoma: a study integrating ultrasonographic features.
    BMC Cancer. 2025;25:803.
    PubMed     Abstract available
    
    
    
77. TAN R, Zhu Y, Chen Z, Feng X, et al
    Clinical correlation and survival analysis of hepatitis B virus infection in oral squamous cell carcinoma: a retrospective study of 1373 patients.
    BMC Cancer. 2025;25:801.
    PubMed     Abstract available
    
    
    
78. YANG XL, Lin L, He SS, Wen DW, et al
    Nasopharyngeal necrosis following intensity-modulated radiation therapy of primary nasopharyngeal carcinoma-incidence rate and predictors of risk.
    BMC Cancer. 2025;25:802.
    PubMed     Abstract available
    
    
    
79. ZHANG X, Wang Z, Zhao Y, Ye H, et al
    Multi-omics analysis unveils a four-gene prognostic signature in esophageal squamous carcinoma and the therapeutic potential of PKP1.
    BMC Cancer. 2025;25:777.
    PubMed     Abstract available
    
    
    
80. HOESSEINI A, Dronkers EAC, Dieleman E, De Herdt MJ, et al
    Rotterdam Oncology Documentation (RONCDOC) - a high-quality data warehouse and tissue collection for head and neck cancer.
    BMC Cancer. 2025;25:778.
    PubMed     Abstract available
    
    
    
81. HADILOU M, Mahdavi N, Keykha E, Ghofrani A, et al
    Artificial intelligence based vision transformer application for grading histopathological images of oral epithelial dysplasia: a step towards AI-driven diagnosis.
    BMC Cancer. 2025;25:780.
    PubMed     Abstract available
    
    
    
82. CHEN X, Jiang Z, Pan J, Xu W, et al
    Integrated multi-omics reveal lactate metabolism-related gene signatures and PYGL in predicting HNSCC prognosis and immunotherapy efficacy.
    BMC Cancer. 2025;25:773.
    PubMed     Abstract available
    
    
    
83. XU XL, Wu CC, Cheng H
    Prognostic significance of preoperative Naples prognostic score for disease-free and overall survival in oral cavity squamous cell carcinoma post-surgery.
    BMC Cancer. 2025;25:757.
    PubMed     Abstract available
    
    
    
84. PANG KL, Li P, Yao XR, Xiao WT, et al
    Deciphering a proliferation-essential gene signature based on CRISPR-Cas9 screening to predict prognosis and characterize the immune microenvironment in HNSCC.
    BMC Cancer. 2025;25:756.
    PubMed     Abstract available
    
    
    
85. XU L, Wang B, Wang C, Mao N, et al
    A model of basement membrane-related regulators for prediction of prognoses in esophageal cancer and verification in vitro.
    BMC Cancer. 2025;25:696.
    PubMed     Abstract available
    
    
    
86. WANG X, Zhang W, Liang K, Wang Y, et al
    Identification of m6 A-regulated ferroptosis biomarkers for prognosis in laryngeal cancer.
    BMC Cancer. 2025;25:694.
    PubMed     Abstract available
    
    
    
87. XIE RL, Cai WL, Ouyang YF, Zou YH, et al
    Effect and safety of immunotherapy among elder patients (age >/= 65) with recurrent or metastatic nasopharyngeal carcinoma.
    BMC Cancer. 2025;25:691.
    PubMed     Abstract available
    
    
    
88. WANG J, Fu W, Luo J, Wei M, et al
    Development of a clinical-molecular prediction model for central lymph node metastasis in cN0 stage papillary thyroid microcarcinoma: a retrospective study.
    BMC Cancer. 2025;25:693.
    PubMed     Abstract available
    
    
    
89. LI P, Pang KL, Chen SJ, Yang D, et al
    ADORA2B promotes proliferation and migration in head and neck squamous cell carcinoma and is associated with immune infiltration.
    BMC Cancer. 2025;25:673.
    PubMed     Abstract available
    
    
    
90. XU X, Sun T, Zhang X, Wang W, et al
    The predicting role of albumin to derived neutrophil-to-lymphocyte ratio for the prognosis of esophageal squamous cell carcinoma patients aged 60 years and above.
    BMC Cancer. 2025;25:652.
    PubMed     Abstract available
    
    
    
91. TAMBA M, Osumi H, Ogura M, Fukuoka S, et al
    Real-world safety and efficacy of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil therapy for locally advanced esophageal squamous cell carcinoma.
    BMC Cancer. 2025;25:636.
    PubMed     Abstract available
    
    
    
92. ZHANG W, Lu P, Li X, Fang Q, et al
    Hypothyroidism following immunotherapy predicts more postoperative complication in oral squamous cell carcinoma.
    BMC Cancer. 2025;25:643.
    PubMed     Abstract available
    
    
    
93. NASCA V, Bergamo F, Foltran L, Antonuzzo L, et al
    Adjuvant TRastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual disease in liquid biopsy after pre-operative chemotherapy and radical
    BMC Cancer. 2025;25:633.
    PubMed     Abstract available
    
    
    
94. TAN C, Li Y, Chen X, Zhu W, et al
    Reirradiation based on diffusion-weighted magnetic resonance imaging-guided dose- painting for locally advanced recurrent nasopharyngeal carcinoma: a phase 2 randomized controlled trial.
    BMC Cancer. 2025;25:622.
    PubMed     Abstract available
    
    
    
95. YANG K, Yue B, Tian H, Wang L, et al
    Paeonol inhibits the Glycolysis in oral squamous cell carcinoma though suppressing NAT10-mediated ac(4)C modification.
    BMC Cancer. 2025;25:629.
    PubMed     Abstract available
    
    
    
96. WEI K, Ma Y, Xu J, Zheng H, et al
    Potential changes in microorganisms and metabolites associated with oral cancer: a preliminary study.
    BMC Cancer. 2025;25:611.
    PubMed     Abstract available
    
    
    
97. YU N, Wan Y, Zuo L, Cao Y, et al
    Multi-modal radiomics features to predict overall survival of locally advanced esophageal cancer after definitive chemoradiotherapy.
    BMC Cancer. 2025;25:596.
    PubMed     Abstract available
    
    
    
98. PAN YX, Huang Q, Xing S, Zhu QY, et al
    A novel serum protein biomarker for the late-stage diagnosis of nasopharyngeal carcinoma.
    BMC Cancer. 2025;25:585.
    PubMed     Abstract available
    
    
    
99. HASIBUZZAMAN MM, He R, Khan IN, Salem AK, et al
    Radiotherapy is enhanced by CPH:SA IL-1alpha microparticles in a murine HNSCC tumor model.
    BMC Cancer. 2025;25:588.
    PubMed     Abstract available
    
    
    
100. GOLESTANNEJAD P, Monkaresi M, Zhian Zargaran F, Khosravani M, et al
     Role of Cancer Associated Fibroblast (CAF) derived miRNAs on head and neck malignancies microenvironment: a systematic review.
     BMC Cancer. 2025;25:582.
     PubMed     Abstract available
     
     
     
101. LIU S, Guan T, Yang F, Zhang H, et al
     Targeting CD276: a promising strategy for CAR-NK cell immunotherapy in human oral tongue squamous cell carcinoma.
     BMC Cancer. 2025;25:593.
     PubMed     Abstract available
     
     
     March 2025
102. LI S, Yu Y, Xu Y, Zhou Y, et al
     Clinicopathological characteristics and the relationship of PD-L1 status, tumor mutation burden, and microsatellite instability in patients with esophageal carcinoma.
     BMC Cancer. 2025;25:576.
     PubMed     Abstract available
     
     
     
103. OUYANG H, Liu Y, He X, Zhang J, et al
     A comparative study of different parameter estimation methods for predictive models of Normal Tissue Complication Probability (NTCP) of radiation-induced temporal lobe injury following intensity-modulated radiotherapy in nasopharyngeal carcinoma.
     BMC Cancer. 2025;25:572.
     PubMed     Abstract available
     
     
     
104. YUKSEL IB, Bahrilli S, Altindag A
     Turkish dental students' knowledge, attitudes, and awareness of oral cancer.
     BMC Cancer. 2025;25:568.
     PubMed     Abstract available
     
     
     
105. BASTIT V, Lequesne J, Leconte A, Deneuve S, et al
     Effectiveness of bilateral tongue base mucosectomy by transoral robotic surgery or transoral laser microsurgery in combination with tonsillectomy in identifying head and neck primary cancer of unknown primary: a randomized phase 2 protocol (RoboCUP tr
     BMC Cancer. 2025;25:551.
     PubMed     Abstract available
     
     
     
106. YIN X, Luo M, Zha X, Duan M, et al
     RBMS1-HSPA8 axis activation drives head and neck squamous cell carcinoma progression.
     BMC Cancer. 2025;25:549.
     PubMed     Abstract available
     
     
     
107. XU Y, Xu M, Geng Z, Liu J, et al
     Thyroid nodule classification in ultrasound imaging using deep transfer learning.
     BMC Cancer. 2025;25:544.
     PubMed     Abstract available
     
     
     
108. JIAN L, Chen MK, Kor CT, Liu YT, et al
     Influence of psoriasis on infection risk and survival outcomes in patients with head and neck cancer: a retrospective cohort study.
     BMC Cancer. 2025;25:534.
     PubMed     Abstract available
     
     
     
109. JIAN L, Sheng C, Liu H, Li H, et al
     Early prediction of progression-free survival of patients with locally advanced nasopharyngeal carcinoma using multi-parametric MRI radiomics.
     BMC Cancer. 2025;25:519.
     PubMed     Abstract available
     
     
     
110. RAST J, Zebralla V, Wald T, Dietz A, et al
     The impact of financial burden on quality of life among German head and neck cancer survivors.
     BMC Cancer. 2025;25:514.
     PubMed     Abstract available
     
     
     
111. WANG L, Wang HM, Tang F, Zhang YT, et al
     The impact of different cervical planning target volume designs on efficacy and toxicity in nasopharyngeal carcinoma: a single-center retrospective study.
     BMC Cancer. 2025;25:485.
     PubMed     Abstract available
     
     
     
112. ZHAO J, Yang G, Li Y, Li S, et al
     Predicting anastomotic leak in patients with esophageal squamous cell cancer treated with neoadjuvant chemoradiotherapy using a nomogram based on CT radiomic and clinicopathologic factors.
     BMC Cancer. 2025;25:484.
     PubMed     Abstract available
     
     
     
113. CHEN Y, Hu R, Jin C, Huang L, et al
     Pilot study of ultrasound-guided microwave ablation for inactivating excess remnant thyroid after surgery in patients with differentiated thyroid cancer.
     BMC Cancer. 2025;25:469.
     PubMed     Abstract available
     
     
     
114. YIN Z, Zhang H, Zhang K, Yue J, et al
     Impacts of combining PD-L1 inhibitor and radiotherapy on the tumour immune microenvironment in a mouse model of esophageal squamous cell carcinoma.
     BMC Cancer. 2025;25:474.
     PubMed     Abstract available
     
     
     
115. SHAMSI U, Arshad MS, Rashid YA, Jehanzeb H, et al
     Determinants of oral cavity cancer recurrence in Pakistan: findings from a cross-sectional study using an institutional cancer registry.
     BMC Cancer. 2025;25:459.
     PubMed     Abstract available
     
     
     
116. HUANG Q, Hu J, Hu W, Gao J, et al
     Clinical outcomes of particle beam radiation therapy for patients with newly-diagnosed major salivary gland tumors.
     BMC Cancer. 2025;25:452.
     PubMed     Abstract available
     
     
     
117. RAY AD, Hong CC, Schlecht NF, Yu H, et al
     Respiratory muscle training reduces painful swallowing and opioid use during radiation therapy for head and neck cancer: a matched pair analysis.
     BMC Cancer. 2025;25:442.
     PubMed     Abstract available
     
     
     
118. XU W, Jiang H, Liu Y, Liu X, et al
     A retrospective cohort study on radio/chemotherapy and survival following esophageal fistula in esophageal cancer patients with prior radiotherapy.
     BMC Cancer. 2025;25:440.
     PubMed     Abstract available
     
     
     
119. YANG J, Zhu Y, Zhou Y, Zhang J, et al
     Potential biomarkers develop for predicting the prognosis of patients with esophageal squamous cell carcinoma after optimized chemoradiotherapy using serum metabolomics.
     BMC Cancer. 2025;25:438.
     PubMed     Abstract available
     
     
     
120. LOU P, Huang Y, Li H, Zhao F, et al
     Predicting central lymph node metastasis in papillary thyroid carcinoma combined with Hashimoto's thyroiditis: a preoperative study.
     BMC Cancer. 2025;25:425.
     PubMed     Abstract available
     
     
     
121. GOMES MCMF, Ferreira PMV, Almeida ACSM, Cornelio JS, et al
     Dysphagia, nutritional status, and quality of life in patients with head and neck cancer undergoing radiotherapy alone or combined with chemotherapy: an observational study.
     BMC Cancer. 2025;25:416.
     PubMed     Abstract available
     
     
     
122. LI Q, Pu G
     SIRT7 affects the proliferation and apoptosis of papillary thyroid cancer cells by desuccinylation of LATS1.
     BMC Cancer. 2025;25:408.
     PubMed     Abstract available
     
     
     
123. TANG H, Guo D, Yang B, Huang SH, et al
     Location based BRAF V600E mutation status and dimension patterns of sporadic thyroid nodules: a population-based study.
     BMC Cancer. 2025;25:406.
     PubMed     Abstract available
     
     
     
124. CHEN X, Song F, Xiao P, Yao Y, et al
     Spermine accumulation via spermine synthase promotes tumor cell proliferation in head and neck squamous cell carcinoma.
     BMC Cancer. 2025;25:402.
     PubMed     Abstract available
     
     
     February 2025
125. WANG Y, Huang S, Huang R
     Two or three weeks of thyroid hormone withdrawal before initial (131)I therapy for patients with differentiated thyroid carcinoma?
     BMC Cancer. 2025;25:370.
     PubMed     Abstract available
     
     
     
126. ZHANG H, Li Y, Li L
     Blood metabolites reflect the effect of gut microbiota on differentiated thyroid cancer: a Mendelian randomization analysis.
     BMC Cancer. 2025;25:368.
     PubMed     Abstract available
     
     
     
127. TRAN KL, Turkdogan S, Dinur AB, Milner TD, et al
     A multi-centre, participant-blinded, randomized, 3-year study to compare the efficacy of Virtual Surgical Planning (VSP) to Freehand Surgery (FHS) on bony union and quality of life outcomes for mandibular reconstruction with fibular and scapular free
     BMC Cancer. 2025;25:358.
     PubMed     Abstract available
     
     
     
128. ALI A, Bari MF, Arshad S, Wahid M, et al
     Tissue-resident memory T-cell expressions and their prognostic role in head and neck squamous cell carcinoma: a systematic review and meta-analysis.
     BMC Cancer. 2025;25:356.
     PubMed     Abstract available
     
     
     
129. ZHANG K, Wang Q, Cao J, Fan C, et al
     Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: a multicenter, randomized, parallel-controlled, phase II clinical trial.
     BMC Cancer. 2025;25:347.
     PubMed     Abstract available
     
     
     
130. PARK YI, Choi SH, Cho MS, Son J, et al
     The potential of thermal imaging as an early predictive biomarker of radiation dermatitis during radiotherapy for head and neck cancer: a prospective study.
     BMC Cancer. 2025;25:309.
     PubMed     Abstract available
     
     
     
131. ZHOU T, Wang X, Zhu Q, Zhou E, et al
     Global trends and risk factors of laryngeal cancer: a systematic analysis for the Global Burden of Disease Study (1990-2021).
     BMC Cancer. 2025;25:296.
     PubMed     Abstract available
     
     
     
132. LI H, Liang S, Cui M, Jin W, et al
     A preoperative pathological staging prediction model for esophageal cancer based on CT radiomics.
     BMC Cancer. 2025;25:298.
     PubMed     Abstract available
     
     
     
133. SMUSSI D, Conti C, Lorini L, Mattavelli D, et al
     Financial toxicity questionnaire (FIT): development and validation of the italian version (FITALY) in head and neck cancer patients undergoing multimodal curative treatment.
     BMC Cancer. 2025;25:283.
     PubMed     Abstract available
     
     
     
134. YIN Y, Zhang W, Zou L, Liu X, et al
     Segmentation methods and dosimetric evaluation of 3D-printed immobilization devices in head and neck radiotherapy.
     BMC Cancer. 2025;25:289.
     PubMed     Abstract available
     
     
     
135. LIMA CR, Geraldo MV, Fuziwara CS, Kimura ET, et al
     Correction: MiRNA-146b-5p upregulates migration and invasion of different papillary thyroid carcinoma cells.
     BMC Cancer. 2025;25:256.
     PubMed    
     
     
     
136. ZHOU HD, Wei Y, Zhao ZL, Peng L, et al
     A clinical study on microwave ablation of T1N0M0 papillary thyroid carcinoma locating in dangerous region.
     BMC Cancer. 2025;25:240.
     PubMed     Abstract available
     
     
     
137. JIANG JL, Chang JT, Huang BS, Chang TY, et al
     Post-irradiation vertebral and carotid stenosis heightens stroke risk in head and neck cancer.
     BMC Cancer. 2025;25:235.
     PubMed     Abstract available
     
     
     
138. ZHAO J, Wang K, Li Y, Hu X, et al
     Impact of radiation dose to immune cells on survival in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a retrospective analysis.
     BMC Cancer. 2025;25:238.
     PubMed     Abstract available
     
     
     
139. HUANG YC, Chen SW, Chiang YS
     Prognostic role of geriatric nutritional risk index (GNRI) and controlling nutritional status (CONUT) on outcomes in patients with head and neck cancer: a systematic review and meta-analysis.
     BMC Cancer. 2025;25:242.
     PubMed     Abstract available
     
     
     
140. DONG Y, Wang F, Deng J, Tong T, et al
     Prognostic value of serum inflammatory markers in patients with esophageal squamous cell carcinoma undergoing surgery: a two-center retrospective cohort study.
     BMC Cancer. 2025;25:213.
     PubMed     Abstract available
     
     
     
141. XU M, Wang L, Ding J, Xu Y, et al
     The prognostic value of boost dose in residual cervical lymph nodes in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy: a retrospective study.
     BMC Cancer. 2025;25:222.
     PubMed     Abstract available
     
     
     
142. LI Y, Cao Y, Wang X, Li C, et al
     Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherap
     BMC Cancer. 2025;25:198.
     PubMed     Abstract available
     
     
     
143. FURUKAWA J, Kakei Y, Murakami S, Kita H, et al
     Safety and efficacy of oral cancer vaccine B440 in patients with PD-1/PD-L1 inhibitor-resistant advanced urothelial cancer: a study protocol for a phase 1 multicenter, open-label, single-arm clinical trial.
     BMC Cancer. 2025;25:195.
     PubMed     Abstract available
     
     
     January 2025
144. CHENG KL, Lu HJ, Shen CY, Lin CW, et al
     Intravoxel incoherent motion (IVIM) MRI-derived masseter muscle characteristics: a new diagnostic marker in head and neck cancer?
     BMC Cancer. 2025;25:184.
     PubMed     Abstract available
     
     
     
145. WANG N, Chen Y, Lin J, Lin Y, et al
     Identification of novel serum lipid metabolism potential markers and metabolic pathways for oral cancer: a population-based study.
     BMC Cancer. 2025;25:177.
     PubMed     Abstract available
     
     
     
146. WANG Z, Yang Y, Ge C, Tian R, et al
     Delineation of reduced CTV2 on the basis of the characteristics and distribution of cervical lymph node metastasis in nasopharyngeal carcinoma.
     BMC Cancer. 2025;25:145.
     PubMed     Abstract available
     
     
     
147. WANG Z, Xiao Z, Zhang T, Lu M, et al
     Development and validation of a novel artificial intelligence algorithm for precise prediction the postoperative prognosis of esophageal squamous cell carcinoma.
     BMC Cancer. 2025;25:134.
     PubMed     Abstract available
     
     
     
148. HTET H, Anaghan JRJ, Jaiprakash H, Burud IAS, et al
     Efficacy and safety of molecular targeted therapies in nasopharyngeal carcinoma: a network meta-analysis.
     BMC Cancer. 2025;25:110.
     PubMed     Abstract available
     
     
     
149. LI X, Yao XY, Liu SR, Mei F, et al
     Gross recurrent laryngeal nerve invasion by extranodal extension in thyroid carcinoma.
     BMC Cancer. 2025;25:109.
     PubMed     Abstract available
     
     
     
150. CAO W, Jin D, Min W, Li H, et al
     Prognostic values of intracellular cell-related genes in esophageal cancer and their regulatory mechanisms.
     BMC Cancer. 2025;25:105.
     PubMed     Abstract available
     
     
     
151. WANG R, Guo T, Wang Q, Gao W, et al
     The efficacy and safety of induction chemotherapy combined with sintilimab followed by concurrent chemoradiotherapy plus sintilimab sequencing maintaining with sintilimab for patients with unresectable locally advanced esophageal squamous cell carcino
     BMC Cancer. 2025;25:97.
     PubMed     Abstract available
     
     
     
152. DENG L, Ran H, Yang D, Wang Z, et al
     TOM40 as a prognostic oncogene for oral squamous cell carcinoma prognosis.
     BMC Cancer. 2025;25:92.
     PubMed     Abstract available
     
     
     
153. YANG M, Zheng G, Chen F, Tang H, et al
     Molecular characterization of EBV-associated primary pulmonary lymphoepithelial carcinoma by multiomics analysis.
     BMC Cancer. 2025;25:85.
     PubMed     Abstract available
     
     
     
154. SOWELL FG, de Milliano T, Brady KJS, Foglia G, et al
     A conceptual model for advanced/metastatic gastric or gastroesophageal junction cancer: a review of qualitative studies and results from patient interviews.
     BMC Cancer. 2025;25:88.
     PubMed     Abstract available
     
     
     
155. HE L, Li L, Zhao L, Guan X, et al
     CircCCT2/miR-146a-5p/IRAK1 axis promotes the development of head and neck squamous cell carcinoma.
     BMC Cancer. 2025;25:84.
     PubMed     Abstract available
     
     
     
156. DUAN X, Yue J, Wang S, Zhao F, et al
     Prognostic role of the pathological status following neoadjuvant chemoradiotherapy and surgery in esophageal squamous cell carcinoma.
     BMC Cancer. 2025;25:61.
     PubMed     Abstract available
     
     
     
157. IITAKA S, Kuroda A, Narita T, Hatakeyama H, et al
     Correction: Evaluation of N-NOSE as a surveillance tool for recurrence in gastric and esophageal cancers: a prospective cohort study.
     BMC Cancer. 2025;25:54.
     PubMed    
     
     
     
158. PIKUL J, Machnicki MM, Rzepakowska A, Winiarska N, et al
     Potentially actionable molecular alterations in particular related to poor oncologic outcomes in salivary gland carcinomas.
     BMC Cancer. 2025;25:42.
     PubMed     Abstract available
     
     
     
159. XU Y, Lin C, Han C, Wang X, et al
     Development of a prognostic nomogram and risk stratification system for elderly patients with esophageal squamous cell carcinoma undergoing definitive radiotherapy: a multicenter retrospective analysis (3JECROG R-03 A).
     BMC Cancer. 2025;25:40.
     PubMed     Abstract available
     
     
     
160. HIKEN J, Earls J, Flanagan KC, Wellinghoff RL, et al
     Analytical performance of OncoPrism-HNSCC, an RNA-based assay to inform immune checkpoint inhibitor treatment decisions for recurrent/metastatic head and neck squamous cell carcinoma.
     BMC Cancer. 2025;25:21.
     PubMed     Abstract available
     
     
     
161. MATIKU S, Murenzi G, Rugengamanzi E, Liwa E, et al
     Androgen receptor overexpression by immunohistochemistry in malignant salivary gland tumors in Tanzania.
     BMC Cancer. 2025;25:29.
     PubMed     Abstract available
     
     
     
162. WANG J, Zhao L, Lin J, Yu Y, et al
     Comparison of mediastinoscopy and thoracoscope minimally invasive esophagectomy in the treatment of esophageal cancer: a meta-analysis and system review.
     BMC Cancer. 2025;25:14.
     PubMed     Abstract available
     
     
     December 2024
163. LIU H, Zhang S, Liu X, Wang Q, et al
     Thyroid cancer survival and prognostic factors in Yantai, China (2012-2022): a population-based study.
     BMC Cancer. 2024;24:1587.
     PubMed     Abstract available
     
     
     
164. ZHENG Y, Xing W, BingWei, Liu X, et al
     Detection of a novel DNA methylation marker panel for esophageal cancer diagnosis using circulating tumor DNA.
     BMC Cancer. 2024;24:1578.
     PubMed     Abstract available
     
     
     
165. ALQAHTANI T, Alsubait A, Aloumi M, Alamer A, et al
     A novel role for nonactin: interfering with G-quadruplex in RET-driven medullary thyroid cancer.
     BMC Cancer. 2024;24:1569.
     PubMed     Abstract available
     
     
     
166. COURTNEY PT, L Santoso M, Savjani RR, K Reddy V, et al
     A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol.
     BMC Cancer. 2024;24:1564.
     PubMed     Abstract available
     
     
     
167. ALMANGUSH A, Alabi RO, Pirinen M, Makitie A, et al
     Accumulating evidence from meta-analyses of prognostic studies on oral cancer: towards biomarker-driven patient selection.
     BMC Cancer. 2024;24:1517.
     PubMed     Abstract available
     
     
     
168. JIANG C, Li J, Peng H, Zhou D, et al
     The clinical target volume delineation based on the correlation analysis of neck node levels in oral cavity squamous cell carcinoma (OCSCC).
     BMC Cancer. 2024;24:1530.
     PubMed     Abstract available
     
     
     
169. CHENG X, Meng F, Wang R, Liu S, et al
     Prognostic value of immuno-inflammatory biomarkers in esophageal squamous cell carcinoma patients receiving immunotherapy combined with chemoradiotherapy and its association with immuno-genomic landscape.
     BMC Cancer. 2024;24:1518.
     PubMed     Abstract available
     
     
     
170. JAVID M, Mirdamadi A, Javid M, Keivanlou MH, et al
     The evolving role of MRI in the detection of extrathyroidal extension of papillary thyroid carcinoma: a systematic review and meta-analysis.
     BMC Cancer. 2024;24:1531.
     PubMed     Abstract available
     
     
     
171. SCHMIDT M, Vernooij R, van Nuland M, Smeijsters E, et al
     Impaired liver function: effect on paclitaxel toxicity, dose modifications and overall survival.
     BMC Cancer. 2024;24:1553.
     PubMed     Abstract available
     
     
     
172. IITAKA S, Kuroda A, Narita T, Hatakeyama H, et al
     Evaluation of N-NOSE as a surveillance tool for recurrence in gastric and esophageal cancers: a prospective cohort study.
     BMC Cancer. 2024;24:1544.
     PubMed     Abstract available
     
     
     
173. ZENG S, Jiang K, Ge J, Tang M, et al
     NTRK fusion promotes tumor migration and invasion through epithelial-mesenchymal transition and closely interacts with ECM1 and NOVA1.
     BMC Cancer. 2024;24:1502.
     PubMed     Abstract available
     
     
     
174. WANG Y, Zhang H, Wang H, Hu Y, et al
     Development of a neoadjuvant chemotherapy efficacy prediction model for nasopharyngeal carcinoma integrating magnetic resonance radiomics and pathomics: a multi-center retrospective study.
     BMC Cancer. 2024;24:1501.
     PubMed     Abstract available
     
     
     
175. MUDIYANSELAGE SB, Nguyen D, Tang B, Williams R, et al
     The epidemiological trends and predictions of esophageal squamous cell carcinoma and gastroesophageal junction carcinoma: an Australian population-based study.
     BMC Cancer. 2024;24:1498.
     PubMed     Abstract available
     
     
     
176. TANG D, Cao C, Li W, Wang A, et al
     FTO-mediated demethylation of MTUS1/ATIP1 promotes tumor progression in head and neck squamous cell carcinoma.
     BMC Cancer. 2024;24:1489.
     PubMed     Abstract available
     
     
     
177. WANG S, Wang Y, Xu J, Ren Q, et al
     Ultrasound characteristics of alveolar soft part sarcoma in pediatric patients: a retrospective analysis.
     BMC Cancer. 2024;24:1484.
     PubMed     Abstract available
     
     
     
178. LIU L, Wang P, Guo C, Song L, et al
     TRAIP enhances progression of tongue squamous cell carcinoma through EMT and Wnt/beta-catenin signaling by interacting with DDX39A.
     BMC Cancer. 2024;24:1481.
     PubMed     Abstract available
     
     
     November 2024
179. KASMANN L, Nieto A, Rennollet R, Gurtner R, et al
     Validation of two predictive models for survival in anaplastic thyroid cancer (ATC).
     BMC Cancer. 2024;24:1477.
     PubMed     Abstract available
     
     
     
180. ZHANG L, Wang S, Wang L
     SKA1/2/3 is a prognostic and predictive biomarker in esophageal adenocarcinoma and squamous cell carcinoma.
     BMC Cancer. 2024;24:1480.
     PubMed     Abstract available
     
     
     
181. XIE JB, Huang SJ, Yang TB, Wang W, et al
     Comparison of machine learning methods for Predicting 3-Year survival in elderly esophageal squamous cancer patients based on oxidative stress.
     BMC Cancer. 2024;24:1432.
     PubMed     Abstract available
     
     
     
182. YANG R, Li T, Zhang S, Shui C, et al
     The effect of circulating tumor DNA on the prognosis of patients with head and neck squamous cell carcinoma: a systematic review and meta-analysis.
     BMC Cancer. 2024;24:1434.
     PubMed     Abstract available
     
     
     
183. LI T, Dai Y, Fu X, Cai Q, et al
     Prospective multicenter study of camrelizumab in real-world settings for asian patients with esophageal squamous cell carcinoma.
     BMC Cancer. 2024;24:1421.
     PubMed     Abstract available
     
     
     
184. CAI M, Gou J
     Symptoms and negative emotions in patients with advanced thyroid cancer: a prospective cross-sectional study.
     BMC Cancer. 2024;24:1418.
     PubMed     Abstract available
     
     
     
185. GUO J, Si G, Song X, Si F, et al
     Association of B cells and the risk of Esophageal cancer: a bidirectional two-sample mendelian randomization study.
     BMC Cancer. 2024;24:1416.
     PubMed     Abstract available
     
     
     
186. ABOOSHAHAB R, Zarkesh M, Sameni M, Akbarzadeh M, et al
     Expression of TSPAN1 and its link to thyroid nodules: one step forward on the path to thyroid tumorigenesis biomarkers.
     BMC Cancer. 2024;24:1414.
     PubMed     Abstract available
     
     
     
187. PAN C, Ng K, Voutsinas J, Barber B, et al
     Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.
     BMC Cancer. 2024;24:1406.
     PubMed     Abstract available
     
     
     
188. ZHOU Y, Zhou J, Cai X, Ge S, et al
     Integrating (18)F-FDG PET/CT radiomics and body composition for enhanced prognostic assessment in patients with esophageal cancer.
     BMC Cancer. 2024;24:1402.
     PubMed     Abstract available
     
     
     
189. NIKKILA R, Hirvonen E, Haapaniemi A, Pitkaniemi J, et al
     Second primary cancers in patients with a pharyngeal index tumour: a register-based cohort study.
     BMC Cancer. 2024;24:1380.
     PubMed     Abstract available
     
     
     
190. YANG Y, Zhang J, Yuan C, Cheng Z, et al
     Recurrent aphthous stomatitis and neoplasms of the mouth and pharynx: a two-sample Mendelian randomization study.
     BMC Cancer. 2024;24:1372.
     PubMed     Abstract available
     
     
     
191. LI P, Zhang X, Fang Q, Du W, et al
     Sentinel lymph node biopsy in cT1-2N0 minor salivary gland cancer in oral cavity.
     BMC Cancer. 2024;24:1349.
     PubMed     Abstract available
     
     
     October 2024
192. ZHANG Y, Xu W, Wu M, Li Y, et al
     Survival risk stratification based on prognosis nomogram to identify patients with esophageal squamous cell carcinoma who may benefit from postoperative adjuvant therapy.
     BMC Cancer. 2024;24:1330.
     PubMed     Abstract available
     
     
     
193. TSAI YT, Chen WC, Wen YW, Lin CY, et al
     Prognostic significance of adjuvant therapy and specific radiation dosages in Taiwanese patients with oral cavity cancer and extra-nodal extension: a nationwide cohort study.
     BMC Cancer. 2024;24:1320.
     PubMed     Abstract available
     
     
     
194. FU LL, Yan M, Yu X, Shao M, et al
     Retinol-binding protein type 1 expression predicts poor prognosis in head and neck squamous cell carcinoma.
     BMC Cancer. 2024;24:1277.
     PubMed     Abstract available
     
     
     
195. BILGIC S, Meral R, Sager MS, Sonmezoglu K, et al
     RAI therapy in low-risk papillary thyroid cancer: recurrence reduction and long-term outcomes in the Turkish population.
     BMC Cancer. 2024;24:1273.
     PubMed     Abstract available
     
     
     
196. ZHANG Y, Meng Z, Lu M, Ruan S, et al
     Study of the significance of the combination of the fibrinogen-albumin ratio and sarcopenia in predicting the prognosis of laryngeal cancer patients undergoing radical surgery.
     BMC Cancer. 2024;24:1265.
     PubMed     Abstract available
     
     
     
197. GHORBANPOUR M, Salarvand S, Salarvand S, Shahsavari F, et al
     Depth of invasion and extranodal extension: the influential factors to predict survival rate of patients with oral tongue squamous cell carcinoma.
     BMC Cancer. 2024;24:1256.
     PubMed     Abstract available
     
     
     
198. XIONG W, Xie Y, Wang D, Huang X, et al
     Aldo-keto reductase family 1 member C3 mediates radioresistance of esophageal cancer cells through suppressing MAPK and AKT signaling.
     BMC Cancer. 2024;24:1236.
     PubMed     Abstract available
     
     
     
199. THARIAT J, Pham TN, Coupey J, Clarisse B, et al
     CYRAD: a translational study assessing immune response to radiotherapy by photons or protons in postoperative head and neck cancer patients through circulating leukocyte subpopulations and cytokine levels.
     BMC Cancer. 2024;24:1230.
     PubMed     Abstract available
     
     
     
200. WANG Y, Ma K, Zhang H, Wu L, et al
     Comparison of pathologic response and survival outcomes between neoadjuvant chemoradiotherapy (nCRT) and neoadjuvant immunochemotherapy (nICT) in patients with locally advanced esophageal squamous cell carcinoma: a propensity score-matched analysis.
     BMC Cancer. 2024;24:1228.
     PubMed     Abstract available
     
     
     
201. YANG MH, Chen TH, Wang HM, Hsieh JC, et al
     Prognostic factors and risk-stratification model of recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimen.
     BMC Cancer. 2024;24:1227.
     PubMed     Abstract available
     
     
     
202. JIN J, Guo SS, Liu LT, Wen DX, et al
     Comparison of long-term quality of life and their predictors in survivors between paediatric and adult nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
     BMC Cancer. 2024;24:1223.
     PubMed     Abstract available
     
     
     
203. RZEPAKOWSKA A, Oledzka J, Daniel P, Mekarska M, et al
     Immunomodulatory role of tumor microenvironment on oncological outcomes in advanced laryngeal cancer.
     BMC Cancer. 2024;24:1219.
     PubMed     Abstract available
     
     
     September 2024
204. THEODORAKI MN, Huber D, Hofmann L, Werner L, et al
     Type 2-like polarization and elevated CXCL4 secretion of monocyte derived macrophages upon internalization of plasma-derived exosomes from head and neck cancer patients.
     BMC Cancer. 2024;24:1173.
     PubMed     Abstract available
     
     
     
205. WEIJERS JAM, Verhaegh GW, Lassche G, van Engen-van Grunsven ACH, et al
     A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma - the DUCT study protocol.
     BMC Cancer. 2024;24:1174.
     PubMed     Abstract available
     
     
     
206. DONG L, Li Y, Song X, Sun C, et al
     SFRP1 mediates cancer-associated fibroblasts to suppress cancer cell proliferation and migration in head and neck squamous cell carcinoma.
     BMC Cancer. 2024;24:1165.
     PubMed     Abstract available
     
     
     
207. YADAV J, Chaudhary A, Tripathi T, Janjua D, et al
     Exosomal transcript cargo and functional correlation with HNSCC patients' survival.
     BMC Cancer. 2024;24:1144.
     PubMed     Abstract available
     
     
     
208. ZHU Y, Xue F
     Comparing long-term efficacy and safety of GP versus TPF sequential chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis.
     BMC Cancer. 2024;24:1145.
     PubMed     Abstract available
     
     
     
209. CHEN J, Wang Y, Wu M, Yu K, et al
     Vasculogenic mimicry triggers early recidivation and resistance to adjuvant therapy in esophageal cancer.
     BMC Cancer. 2024;24:1132.
     PubMed     Abstract available
     
     
     
210. ZHANG SL, Wu ZY, Fan RX, Jia J, et al
     Managing malignant sublingual gland tumors: a single institution experience with 23 patients.
     BMC Cancer. 2024;24:1135.
     PubMed     Abstract available
     
     
     
211. DUAN W, Wu Z, Jiang H, Liao G, et al
     Preoperative thromboelastography parameters in predicting the tumour stage of oral squamous cell carcinoma.
     BMC Cancer. 2024;24:1136.
     PubMed     Abstract available
     
     
     
212. LIU H, Lei L, Song S, Geng X, et al
     The serological diagnostic value of EBV-related IgA antibody panels for nasopharyngeal carcinoma: a diagnostic test accuracy meta-analysis.
     BMC Cancer. 2024;24:1115.
     PubMed     Abstract available
     
     
     
213. KERSEN J, Roach P, Chandarana S, Ronksley P, et al
     Exploring transitions in care among patients with head and neck CANCER: a multimethod study.
     BMC Cancer. 2024;24:1108.
     PubMed     Abstract available
     
     
     
214. MACDONALD C, Fitch M, Hutcheson KA, McCulloch TM, et al
     A protocol for stakeholder engagement in head and neck cancer pragmatic trials.
     BMC Cancer. 2024;24:1109.
     PubMed     Abstract available
     
     
     
215. HUANG J, Yu Y, Wu Z, Wu C, et al
     Thoracoscopic three-port single versus multiple intercostal for radical resection of esophageal cancer: a retrospective analysis.
     BMC Cancer. 2024;24:1104.
     PubMed     Abstract available
     
     
     
216. YAO J, Zhao X, Chen J, Liu T, et al
     Treatment strategies for elderly patients with locally advanced esophageal cancer: a systematic review and meta-analysis.
     BMC Cancer. 2024;24:1101.
     PubMed     Abstract available
     
     
     
217. SHARMA S, Mittal M, Shukla A, Khan J, et al
     Exploring serine-arginine rich splicing factors: potential predictive markers for dysregulation in oral cancer.
     BMC Cancer. 2024;24:1094.
     PubMed     Abstract available
     
     
     
218. HAN D, Dong J, Wang Q, Li B, et al
     Neoadjuvant radiation target volume definition in esophageal squamous cell cancer: a multicenter recommendations from Chinese experts.
     BMC Cancer. 2024;24:1086.
     PubMed     Abstract available
     
     
     August 2024
219. HE T, Shi S, Liu Y, Zhu L, et al
     Pathology diagnosis of intraoperative frozen thyroid lesions assisted by deep learning.
     BMC Cancer. 2024;24:1069.
     PubMed     Abstract available
     
     
     
220. ZHANG J, Gong J, Liu H, Zhou W, et al
     Prognostic nutritional index predicts lateral lymph node metastasis and recurrence free survival in papillary thyroid carcinoma.
     BMC Cancer. 2024;24:1039.
     PubMed     Abstract available
     
     
     
221. QI WX, Li S, Li H, Chen J, et al
     The addition of pembrolizumab to neoadjuvant chemoradiotherapy did not increase the risk of developing postoperative anastomotic leakage for ESCC: an analysis from a prospective cohort.
     BMC Cancer. 2024;24:1029.
     PubMed     Abstract available
     
     
     
222. ZHANG C, Wang SF, Zhang YL, Teng CX, et al
     Peripheral hemoglobin to albumin ratio predicts prognosis in patients with nasopharyngeal carcinoma underwent concurrent chemoradiotherapy.
     BMC Cancer. 2024;24:1012.
     PubMed     Abstract available
     
     
     
223. PARK JO, Feng YH, Su WC, Oh DY, et al
     Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial.
     BMC Cancer. 2024;24:1006.
     PubMed     Abstract available
     
     
     
224. SHEYKHBAHAEI N, Tameemi AHA, Koopaie M
     Effect of short-term fasting on the cisplatin activity in human oral squamous cell carcinoma cell line HN5 and chemotherapy side effects.
     BMC Cancer. 2024;24:989.
     PubMed     Abstract available
     
     
     
225. FANG CH, Cheng YF, Lin SR, Lai WY, et al
     Establishment of a protocol for rapidly expanding Epstein-Barr-virus-specific cytotoxic T cells with enhanced cytotoxicity.
     BMC Cancer. 2024;24:980.
     PubMed     Abstract available
     
     
     
226. ALARCON-SANCHEZ MA, Escoto-Vasquez LS, Heboyan A
     Salivary 8-hydroxy-2'-deoxyguanosine levels in patients with oral cancer: a systematic review and meta-analysis.
     BMC Cancer. 2024;24:960.
     PubMed     Abstract available
     
     
     
227. JIANG L, Zhu J, Chen X, Wang Y, et al
     Reduction in chemotherapy relative dose intensity decreases overall survival of neoadjuvant chemoradiotherapy in patients with locally advanced esophageal carcinoma.
     BMC Cancer. 2024;24:945.
     PubMed     Abstract available
     
     
     
228. GUO LF, Rao MY, Yu YF, Lin Q, et al
     The addition of nimotuzumab during concurrent chemoradiotherapy improved survival outcomes in locally advanced nasopharyngeal carcinoma patients with optimal response to induction chemotherapy.
     BMC Cancer. 2024;24:950.
     PubMed     Abstract available
     
     
     
229. NDEMELA LM, Ottoman OM, Chitemo HD, Minja CA, et al
     Epidemiological distribution of high-risk human papillomavirus genotypes and associated factors among patients with esophageal carcinoma at Bugando medical center in Mwanza, Tanzania.
     BMC Cancer. 2024;24:932.
     PubMed     Abstract available
     
     
     July 2024
230. LIANG J, Fang F, Gao X, Shi J, et al
     LncRNA NEAT1 promotes proliferation, migration, and invasion of laryngeal squamous cell carcinoma cells through miR-411-3p/FZD3-mediated Wnt signaling pathway.
     BMC Cancer. 2024;24:904.
     PubMed     Abstract available
     
     
     
231. CHO BC, Brana I, Cirauqui B, Aksoy S, et al
     Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study.
     BMC Cancer. 2024;23.
     PubMed     Abstract available
     
     
     
232. SADAFI S, Choubsaz P, Kazemeini SMM, Imani MM, et al
     Glutathione S-transferase theta 1 (GSTT1) deletion polymorphism and susceptibility to head and neck carcinoma: a systematic review with five analyses.
     BMC Cancer. 2024;24:885.
     PubMed     Abstract available
     
     
     
233. HIRATA K, Yoshida K, Katada C, Watanabe A, et al
     Definitive chemoradiotherapy with paclitaxel for locally advanced esophageal squamous cell carcinoma in older patients (PARADISE-1): a phase I trial.
     BMC Cancer. 2024;24:873.
     PubMed     Abstract available
     
     
     
234. ZHONG Y, Sun R, Li W, Wang W, et al
     Risk factors for esophageal anastomotic stricture after esophagectomy: a meta-analysis.
     BMC Cancer. 2024;24:872.
     PubMed     Abstract available
     
     
     
235. XIAO L, Liu Y, Zhang X, Nie X, et al
     Prognostic value of sarcopenia and inflammatory indices synergy in patients with esophageal squamous cell carcinoma undergoing chemoradiotherapy.
     BMC Cancer. 2024;24:860.
     PubMed     Abstract available
     
     
     
236. DIETZE A, Neyer PJ, Speth MM, Metzler P, et al
     Therapy-Associated Saliva and Taste change Evaluation (TASTE) in head & neck cancer patients undergoing radiotherapy: a study protocol.
     BMC Cancer. 2024;24:865.
     PubMed     Abstract available
     
     
     
237. KY TD, Loan NT, Thinh NT, Binh MT, et al
     Nonadherence to oral cancer chemotherapy in hepatocellular carcinoma: prevalence and predictive factors in Vietnam.
     BMC Cancer. 2024;24:841.
     PubMed     Abstract available
     
     
     
238. VIRK J, Gill J, Fekrmandi F, Iovoli A, et al
     Association of low adherence to weekly cisplatin with outcomes in patients with head and neck squamous cell carcinoma: a retrospective cohort study.
     BMC Cancer. 2024;24:838.
     PubMed     Abstract available
     
     
     
239. FARHADI M, Fadavi P, Mohebbi S, Taghizadeh-Hesary F, et al
     A new approach to prevent radiation-induced xerostomia using intraglandular injection of mitochondria-boosting agents.
     BMC Cancer. 2024;24:832.
     PubMed     Abstract available
     
     
     
240. NANKIVELL P, Gaunt P, Gaunt C, Sissons J, et al
     PET-CT-guided, symptom-based, patient-initiated surveillance versus clinical follow-up in head neck cancer patients (PETNECK2): study protocol for a multicentre feasibility study and non-inferiority, randomised, phase III trial.
     BMC Cancer. 2024;24:823.
     PubMed     Abstract available
     
     
     
241. CHAI J, Su M, Zhang R, Li N, et al
     Selective anti-tumor activity of glutathione-responsive abasic site trapping agent in anaplastic thyroid carcinoma.
     BMC Cancer. 2024;24:816.
     PubMed     Abstract available
     
     
     
242. ZHOU B, Liu J, Yang Y, Ye X, et al
     Ultrasound-based nomogram to predict the recurrence in papillary thyroid carcinoma using machine learning.
     BMC Cancer. 2024;24:810.
     PubMed     Abstract available
     
     
     
243. LI W, Li Y, Gao S, Huang N, et al
     Integrating lipid metabolite analysis with MRI-based transformer and radiomics for early and late stage prediction of oral squamous cell carcinoma.
     BMC Cancer. 2024;24:795.
     PubMed     Abstract available
     
     
     
244. LIN S, Zhou H, Chen G, Xue J, et al
     Early change of plasma Epstein-Barr virus DNA load and the viral lytic genome level could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti-programmed cell death 1 monotherapy.
     BMC Cancer. 2024;24:797.
     PubMed     Abstract available
     
     
     
245. CHENG Y, Song Z, Cheng J, Tang Z, et al
     JARID2, a novel regulatory factor, promotes cell proliferation, migration, and invasion in oral squamous cell carcinoma.
     BMC Cancer. 2024;24:793.
     PubMed     Abstract available
     
     
     June 2024
246. ALIM N, Elsheikh M, Satti AA, Tabassum N, et al
     Recurrence of oral squamous cell carcinoma in surgically treated patients at Khartoum Teaching Dental Hospital retrospective cross-sectional study.
     BMC Cancer. 2024;24:781.
     PubMed     Abstract available
     
     
     
247. ZHANG M, Li Z, Yin Y
     Association of effective dose to immune cells and vertebral marrow dose with hematologic toxicity during neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma.
     BMC Cancer. 2024;24:779.
     PubMed     Abstract available
     
     
     
248. WONGPATTARAWORAKUL W, Choi A, Buchakjian MR, Lanzel EA, et al
     Prognostic Role of Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma.
     BMC Cancer. 2024;24:766.
     PubMed     Abstract available
     
     
     
249. HUA X, Xu F, Shi W, Long ZQ, et al
     Prognostic significance of platelet?to?albumin ratio in patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: a retrospective study of 858 cases.
     BMC Cancer. 2024;24:762.
     PubMed     Abstract available
     
     
     
250. ATULA M, Atula T, Aro K, Irjala H, et al
     Psychosocial factors and patient and healthcare delays in large (class T3-T4) oral, oropharyngeal, and laryngeal carcinomas.
     BMC Cancer. 2024;24:760.
     PubMed     Abstract available
     
     
     
251. HU J, Dai C, Ding Z, Pan Y, et al
     IKBIP promotes tumor development via the akt signaling pathway in esophageal squamous cell carcinoma.
     BMC Cancer. 2024;24:759.
     PubMed     Abstract available
     
     
     
252. HU W, Hu J, Huang Q, Gao J, et al
     Long-term outcomes after particle radiation therapy in patients with nasopharyngeal adenoid cystic carcinoma.
     BMC Cancer. 2024;24:742.
     PubMed     Abstract available
     
     
     
253. ZENG W, Xu W, Long W
     The association between XPD rs13181 and rs1799793 polymorphism and oral cancer risk: evidence from a meta-analysis.
     BMC Cancer. 2024;24:738.
     PubMed     Abstract available
     
     
     
254. WANG X, Liu C, Wu H, Gu Y, et al
     Basement membrane-associated gene expression as a predictor of survival in oral cancer.
     BMC Cancer. 2024;24:731.
     PubMed     Abstract available
     
     
     
255. XU H, Yang Z, Hu W, Zhou X, et al
     CSPG4P12 polymorphism served as a susceptibility marker for esophageal cancer in Chinese population.
     BMC Cancer. 2024;24:729.
     PubMed     Abstract available
     
     
     
256. XU XL, Xu JH, He JQ, Li YH, et al
     Novel prognostic nomograms for postoperative patients with oral cavity squamous cell carcinoma in the central region of China.
     BMC Cancer. 2024;24:730.
     PubMed     Abstract available
     
     
     
257. HUANG G, Wang Y, Qin B, Zeng J, et al
     Global, regional and national burdens of Nasopharynx cancer in the adolescents and young adults from 1990 to 2019 and its predictions.
     BMC Cancer. 2024;24:720.
     PubMed     Abstract available
     
     
     
258. WANG Y, Li X, Gang Q, Huang Y, et al
     Pathomics and single-cell analysis of papillary thyroid carcinoma reveal the pro-metastatic influence of cancer-associated fibroblasts.
     BMC Cancer. 2024;24:710.
     PubMed     Abstract available
     
     
     
259. SUN Y, Liu Y, Li H, Tang Y, et al
     The significance and prognostic value of multifocal papillary thyroid carcinoma in children and adolescents.
     BMC Cancer. 2024;24:690.
     PubMed     Abstract available
     
     
     
260. PIOREK A, Pluzanski A, Knetki-Wroblewska M, Winiarczyk K, et al
     Treatment outcomes of patients with primary tracheal tumors - analysis of a large retrospective series.
     BMC Cancer. 2024;24:686.
     PubMed     Abstract available
     
     
     
261. WANG L, Liu L, Cao Y, Chen X, et al
     Simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) combined with nimotuzumab for locally advanced esophageal squamous cell carcinoma (ESCC): A phase II clinical trial.
     BMC Cancer. 2024;24:679.
     PubMed     Abstract available
     
     
     
262. VERA R, Castro N, Labiano I, Lecumberri A, et al
     The TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of Spain.
     BMC Cancer. 2024;24:668.
     PubMed     Abstract available
     
     
     May 2024
263. FANG Q, Yuan J, Zhang X, Dai L, et al
     Lymph node metastasis in cutaneous squamous cell carcinoma of the head and neck.
     BMC Cancer. 2024;24:656.
     PubMed     Abstract available
     
     
     
264. YANG X, Zheng X, Hu S, Huang J, et al
     Immune checkpoint inhibitors as the second-line treatment for advanced esophageal squamous cell carcinoma: a cost-effectiveness analysis based on network meta-analysis.
     BMC Cancer. 2024;24:654.
     PubMed     Abstract available
     
     
     
265. ZHENG DD, Li YY, Yuan XY, Lu JL, et al
     Immune cell patterns before and after neoadjuvant immune checkpoint blockade combined with chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.
     BMC Cancer. 2024;24:649.
     PubMed     Abstract available
     
     
     
266. MOU Y, Liang P, Cheng X, He X, et al
     Influence of radiotherapy interruption on esophageal cancer with intensity-modulated radiotherapy: a retrospective study.
     BMC Cancer. 2024;24:646.
     PubMed     Abstract available
     
     
     
267. ZHOU J, Wang L, Qiu T, Gao H, et al
     Long-term follow-up of protective effects on salivary and swallowing structures and improvement of late xerostomia and dysphagia by level IIb optimisation in clinical target volume of nasopharyngeal carcinoma.
     BMC Cancer. 2024;24:648.
     PubMed     Abstract available
     
     
     
268. ERALP B, Sefer E
     Reference-free inferring of transcriptomic events in cancer cells on single-cell data.
     BMC Cancer. 2024;24:607.
     PubMed     Abstract available
     
     
     
269. RONG Y, Hao Y, Wei D, Li Y, et al
     Association between preoperative anxiety states and postoperative complications in patients with esophageal cancer and COPD: a retrospective cohort study.
     BMC Cancer. 2024;24:606.
     PubMed     Abstract available
     
     
     
270. ZONG L, Liu G, He H, Huang D, et al
     Causal association of sleep traits with the risk of thyroid cancer: A mendelian randomization study.
     BMC Cancer. 2024;24:605.
     PubMed     Abstract available
     
     
     
271. WANG J, Lin J, Wang R, Tong T, et al
     Immunotherapy combined with apatinib in the treatment of advanced or metastatic gastric/gastroesophageal tumors: a systematic review and meta-analysis.
     BMC Cancer. 2024;24:603.
     PubMed     Abstract available
     
     
     
272. DU R, Fan S, Yang D, Wang X, et al
     Exploration of lymph node recurrence patterns and delineation guidelines of radiation field in middle thoracic oesophageal carcinomas after radical surgery: a real-world study.
     BMC Cancer. 2024;24:596.
     PubMed     Abstract available
     
     
     
273. LIU H, Li K, Xia J, Zhu J, et al
     Prediction of esophageal cancer risk based on genetic variants and environmental risk factors in Chinese population.
     BMC Cancer. 2024;24:598.
     PubMed     Abstract available
     
     
     
274. PAN Y, Chen Z, Hong W, Huang Z, et al
     A nomogram based on nutritional and inflammatory parameters to predict DMFS and identify beneficiaries of adjuvant chemotherapy in IVA-stage nasopharyngeal carcinoma.
     BMC Cancer. 2024;24:578.
     PubMed     Abstract available
     
     
     
275. WU WB, Cai WL, Zou YH, You R, et al
     Outcomes of patients in nasopharyngeal adenoid cystic carcinoma in the IMRT era: a single-center experience.
     BMC Cancer. 2024;24:576.
     PubMed     Abstract available
     
     
     
276. ZHANG X, Sun K, Gan R, Yan Y, et al
     WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical beta-catenin pathway.
     BMC Cancer. 2024;24:564.
     PubMed     Abstract available
     
     
     
277. HUANG S, Zhang J, He P, Cui X, et al
     Radiation-induced upregulation of FGL1 promotes esophageal squamous cell carcinoma metastasis via IMPDH1.
     BMC Cancer. 2024;24:557.
     PubMed     Abstract available
     
     
     April 2024
278. VIANA VELOSO GG, Amaral FD, Nogueira-Rodrigues A
     Impact of COVID-19 pandemic among patients with lung and head and neck cancer assisted in a public cancer center in Brazil.
     BMC Cancer. 2024;24:539.
     PubMed     Abstract available
     
     
     
279. LI C, Li M, Wei W, Wang Z, et al
     Association of DOK3 and infiltrated tumor-associated macrophages with risk for the prognosis of Porphyromonas gingivalis-infected oral cancer: a 12-year data analysis of 200 patients from a tertiary teaching hospital, Urumqi, China.
     BMC Cancer. 2024;24:534.
     PubMed     Abstract available
     
     
     
280. DONG Z, Wang GY, Dai DY, Qin GJ, et al
     Correction: Prognostic value of pre-treatment [(18)F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis.
     BMC Cancer. 2024;24:528.
     PubMed    
     
     
     
281. JIANG T, Chen C, Zhou Y, Cai S, et al
     Deep learning-assisted diagnosis of benign and malignant parotid tumors based on ultrasound: a retrospective study.
     BMC Cancer. 2024;24:510.
     PubMed     Abstract available
     
     
     
282. SHEN J, Ma Z, Yang J, Qu T, et al
     CircPHGDH downregulation decreases papillary thyroid cancer progression through miR-122-5p/PKM2 axis.
     BMC Cancer. 2024;24:511.
     PubMed     Abstract available
     
     
     
283. JOHANSSON B, Cajander A, Ahmad A, Ohlsson-Nevo E, et al
     The effect of internet-administered support (carer eSupport) on preparedness for caregiving in informal caregivers of patients with head and neck cancer compared with support as usual: a study protocol for a randomized controlled trial.
     BMC Cancer. 2024;24:494.
     PubMed     Abstract available
     
     
     
284. CIRILLO A, Marinelli D, Romeo U, Messineo D, et al
     Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
     BMC Cancer. 2024;24:487.
     PubMed    
     
     
     
285. CHEN Y, Huang Y, Chen X, Chen Z, et al
     Efficacy of salvage surgery versus re-irradiation for isolated regional lymph node recurrence in patients with nasopharyngeal carcinoma.
     BMC Cancer. 2024;24:483.
     PubMed     Abstract available
     
     
     
286. MALEKI Z, Hassanzadeh J, Ghaem H
     Correlation between socioeconomic indices and epidemiological indices of thyroid cancer from 1990 to 2019 year: a global ecologic study.
     BMC Cancer. 2024;24:467.
     PubMed     Abstract available
     
     
     
287. DONG Z, Wang GY, Dai DY, Qin GJ, et al
     Prognostic value of pre-treatment [(18)F] FDG PET/CT in recurrent nasopharyngeal carcinoma without distant metastasis.
     BMC Cancer. 2024;24:466.
     PubMed     Abstract available
     
     
     
288. ELTOHAMI Y, Suleiman A
     Survival analysis of Sudanese oral squamous cell carcinoma patients with field of cancerization.
     BMC Cancer. 2024;24:473.
     PubMed     Abstract available
     
     
     
289. MAN Q, Li P, Fan J, Yang S, et al
     The prognostic role of pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy.
     BMC Cancer. 2024;24:464.
     PubMed     Abstract available
     
     
     
290. YANG Y, Yi Y, Wang Z, Li S, et al
     A combined nomogram based on radiomics and hematology to predict the pathological complete response of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.
     BMC Cancer. 2024;24:460.
     PubMed     Abstract available
     
     
     
291. IDEL C, Fleckner J, Plotze-Martin K, Werner L, et al
     Partial recovery of peripheral blood monocyte subsets in head and neck squamous cell carcinoma patients upon radio(chemo)therapy is associated with decreased plasma CXCL11.
     BMC Cancer. 2024;24:459.
     PubMed     Abstract available
     
     
     
292. DEUTSCH F, Sais D, Keatinge N, Hill M, et al
     Biplex quantitative PCR to detect transcriptionally active human papillomavirus 16 from patient saliva.
     BMC Cancer. 2024;24:442.
     PubMed     Abstract available
     
     
     
293. ROUTILA E, Mahran R, Salminen S, Irjala H, et al
     Identification of stemness-related glycosylation changes in head and neck squamous cell carcinoma.
     BMC Cancer. 2024;24:443.
     PubMed     Abstract available
     
     
     
294. CAO X, Wang X, Song J, Su Y, et al
     Pretreatment multiparametric MRI radiomics-integrated clinical hematological biomarkers can predict early rapid metastasis in patients with nasopharyngeal carcinoma.
     BMC Cancer. 2024;24:435.
     PubMed     Abstract available
     
     
     
295. CIRILLO A, Marinelli D, Romeo U, Messineo D, et al
     Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
     BMC Cancer. 2024;24:430.
     PubMed     Abstract available
     
     
     
296. WANG H, Zhang C, Li Q, Tian T, et al
     Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches.
     BMC Cancer. 2024;24:427.
     PubMed     Abstract available
     
     
     
297. CHEN W, Lin G, Chen Y, Cheng F, et al
     Prediction of the Ki-67 expression level in head and neck squamous cell carcinoma with machine learning-based multiparametric MRI radiomics: a multicenter study.
     BMC Cancer. 2024;24:418.
     PubMed     Abstract available
     
     
     
298. AWNY S, Abdallah A, Metwally IH, Abdelwahab K, et al
     Impact of age on central lymph nodes involvement in papillary thyroid cancer.
     BMC Cancer. 2024;24:423.
     PubMed     Abstract available
     
     
     
299. LI J, Gao X, Sun X, Li H, et al
     Investigating the causal role of the gut microbiota in esophageal cancer and its subtypes: a two-sample Mendelian randomization study.
     BMC Cancer. 2024;24:416.
     PubMed     Abstract available
     
     
     
300. AVRY F, Roseau C, Leguay Z, Brabant S, et al
     Evaluation of a new score associated with acute kidney injury in patients treated with cisplatin based EXTREME regimen.
     BMC Cancer. 2024;24:405.
     PubMed     Abstract available
     
     
     
301. KRIELLAARS Y, Vermaire JA, Beugeling M, Poorter R, et al
     The effect of physical exercise during radiotherapy on physical performance in patients with head and neck cancer: a trial within cohorts study protocol, the vital study.
     BMC Cancer. 2024;24:403.
     PubMed     Abstract available
     
     
     March 2024
302. CUI C, Wang L, Wang X
     Effects of physical and psychological symptoms on cancer-related fatigue among esophageal cancer patients.
     BMC Cancer. 2024;24:398.
     PubMed     Abstract available
     
     
     
303. CHEN Y, Yin M, Zhang Y, Zhou N, et al
     Imprinted gene detection effectively improves the diagnostic accuracy for papillary thyroid carcinoma.
     BMC Cancer. 2024;24:359.
     PubMed     Abstract available
     
     
     
304. DAVAATSEND O, Altannamar M, Ganbat M, Jagdagsuren U, et al
     Factors associated with recurrence in patients with oral cancer in Mongolia.
     BMC Cancer. 2024;24:356.
     PubMed     Abstract available
     
     
     
305. FAN C, Wang X, Zheng X, Sun Y, et al
     Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trial.
     BMC Cancer. 2024;24:321.
     PubMed     Abstract available
     
     
     
306. KHANNA D, Sharma P, Budukh A, Vishwakarma R, et al
     Rural-urban disparity in cancer burden and care: findings from an Indian cancer registry.
     BMC Cancer. 2024;24:308.
     PubMed     Abstract available
     
     
     
307. FUKUDA H, Uehara T, Nakajima T, Iwaya M, et al
     A preliminary study of IgG4 expression and its prognostic significance in oral squamous cell carcinoma.
     BMC Cancer. 2024;24:294.
     PubMed     Abstract available
     
     
     February 2024
308. HU Z, Wang L, Lu M, Yang W, et al
     Protect the recurrent laryngeal nerves in US-guided microwave ablation of thyroid nodules at Zuckerkandl tubercle: a pilot study.
     BMC Cancer. 2024;24:271.
     PubMed     Abstract available
     
     
     
309. ZHENG T, Wang L, Wang H, Tang L, et al
     Prediction model based on MRI morphological features for distinguishing benign and malignant thyroid nodules.
     BMC Cancer. 2024;24:256.
     PubMed     Abstract available
     
     
     
310. GONG L, Li P, Liu J, Liu Y, et al
     A nomogram for predicting adverse pathologic features in low-risk papillary thyroid microcarcinoma.
     BMC Cancer. 2024;24:244.
     PubMed     Abstract available
     
     
     
311. YANG Y, Tan H, Lu Y, Mei J, et al
     Combined score based on plasma fibrinogen and platelet-lymphocyte ratio as a prognostic biomarker in esophageal squamous cell carcinoma.
     BMC Cancer. 2024;24:249.
     PubMed     Abstract available
     
     
     
312. HUANG X, Chen X, Wan G, Yang D, et al
     Mechanism of intestinal microbiota disturbance promoting the occurrence and development of esophageal squamous cell carcinoma--based on microbiomics and metabolomics.
     BMC Cancer. 2024;24:245.
     PubMed     Abstract available
     
     
     
313. DE MORAES FCA, Pasqualotto E, Chavez MP, Ferreira ROM, et al
     Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis of randomized clinical trials.
     BMC Cancer. 2024;24:240.
     PubMed     Abstract available
     
     
     
314. QIU P, Guo Q, Pan K, Lin J, et al
     Development of a nomogram for prediction of central lymph node metastasis of papillary thyroid microcarcinoma.
     BMC Cancer. 2024;24:235.
     PubMed     Abstract available
     
     
     
315. YASSIN-KASSAB A, Chatterjee S, Khan N, Wang N, et al
     p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer.
     BMC Cancer. 2024;24:233.
     PubMed     Abstract available
     
     
     
316. YU XW, She PW, Chen FC, Chen YY, et al
     Metabolic subtypes and immune landscapes in esophageal squamous cell carcinoma: prognostic implications and potential for personalized therapies.
     BMC Cancer. 2024;24:230.
     PubMed     Abstract available
     
     
     
317. TAN R, Zhu X, Sun Y, Yang S, et al
     The association of HBV infection and head and neck cancer: a systematic review and meta-analysis.
     BMC Cancer. 2024;24:225.
     PubMed     Abstract available
     
     
     
318. ALMANGUSH A, Hagstrom J, Haglund C, Kowalski LP, et al
     The prognostic role of single cell invasion and nuclear diameter in early oral tongue squamous cell carcinoma.
     BMC Cancer. 2024;24:213.
     PubMed     Abstract available
     
     
     
319. JAKSTAS T, Bartnykaite A, Padervinskis E, Vegiene A, et al
     The association of E2F1 and E2F2 single nucleotide polymorphisms with laryngeal squamous cell carcinoma pathomorphological features.
     BMC Cancer. 2024;24:214.
     PubMed     Abstract available
     
     
     
320. WU Y, Chen W, Miao H, Xu T, et al
     SIRT7 promotes the proliferation and migration of anaplastic thyroid cancer cells by regulating the desuccinylation of KIF23.
     BMC Cancer. 2024;24:210.
     PubMed     Abstract available
     
     
     
321. ZHU Z, Wang W, Zha Y, Wang X, et al
     Development and validation of a nomogram for predicting overall survival in patients with sinonasal mucosal melanoma.
     BMC Cancer. 2024;24:184.
     PubMed     Abstract available
     
     
     
322. LU RD, Wei ZD, Liu YX, Tian D, et al
     Increased resected lymph node stations improved survival of esophageal squamous cell carcinoma.
     BMC Cancer. 2024;24:177.
     PubMed     Abstract available
     
     
     January 2024
323. WEI B, Yao J, Peng C, Zhao S, et al
     Correction: Clinical features and imaging examination assessment of cervical lymph nodes for thyroid carcinoma.
     BMC Cancer. 2024;24:145.
     PubMed    
     
     
     
324. SAKAMOTO K, Hiraoka SI, Kawamura K, Ruan P, et al
     Automated evaluation of masseter muscle volume: deep learning prognostic approach in oral cancer.
     BMC Cancer. 2024;24:128.
     PubMed     Abstract available
     
     
     
325. ZHANG Y, Du H, Wang N, Wang L, et al
     An update of clinical value of circulating tumor DNA in esophageal cancer: a systematic review and meta-analysis.
     BMC Cancer. 2024;24:129.
     PubMed     Abstract available
     
     
     
326. LV T, Liu H, Mao L, Song Y, et al
     Cancer-associated fibroblast-derived extracellular vesicles promote lymph node metastases in oral cavity squamous cell carcinoma by encapsulating ITGB1 and BMI1.
     BMC Cancer. 2024;24:113.
     PubMed     Abstract available
     
     
     
327. PAN XB, Lu Y, Wei YS, Yao DS, et al
     Efficacy of treatment patterns based on concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma.
     BMC Cancer. 2024;24:106.
     PubMed     Abstract available
     
     
     
328. VAN BEERS MA, Speksnijder CM, van Gils CH, Frederix GWJ, et al
     Prophylactic pectoralis major flap to compensate for increased risk of pharyngocutaneous fistula in laryngectomy patients with low skeletal muscle mass (PECTORALIS): study protocol for a randomized controlled trial.
     BMC Cancer. 2024;24:76.
     PubMed     Abstract available
     
     
     
329. GAO Y, Wang W, Yang Y, Xu Z, et al
     An integrated model incorporating deep learning, hand-crafted radiomics and clinical and US features to diagnose central lymph node metastasis in patients with papillary thyroid cancer.
     BMC Cancer. 2024;24:69.
     PubMed     Abstract available
     
     
     
330. GHASEMIAN A, Sargeran K, Khami MR, Shamshiri AR, et al
     Effects of educational interventions based on the theory of planned behavior on oral cancer-related knowledge and tobacco smoking in adults: a cluster randomized controlled trial.
     BMC Cancer. 2024;24:45.
     PubMed     Abstract available
     
     
     
331. LIU Q, Yuan Y, Shang X, Xin L, et al
     Cyclin B2 impairs the p53 signaling in nasopharyngeal carcinoma.
     BMC Cancer. 2024;24:25.
     PubMed     Abstract available
     
     
     
332. WANG C, Hou Y, Wang L, Yang Y, et al
     Analysis of correlative risk factors for radiation-induced hypothyroidism in head and neck tumors.
     BMC Cancer. 2024;24:5.
     PubMed     Abstract available
     
     
     
333. YU K, Liu S, Lin Z, Song J, et al
     Effect of trace element mixtures on the outcome of patients with esophageal squamous cell carcinoma: a prospective cohort study in Fujian, China.
     BMC Cancer. 2024;24:24.
     PubMed     Abstract available
     
     
     December 2023
334. XU H, Li W, Zhang H, Wang H, et al
     Preliminary evidence for endoscopic surgery combined with postoperative anti-PD-1 immunotherapy in advanced recurrent nasopharyngeal carcinoma.
     BMC Cancer. 2023;23:1259.
     PubMed     Abstract available
     
     
     
335. XING J, Gu Y, Song Y, Liu Q, et al
     MYO5A overexpression promotes invasion and correlates with low lymphocyte infiltration in head and neck squamous carcinoma.
     BMC Cancer. 2023;23:1267.
     PubMed     Abstract available
     
     
     
336. ZHOU J, Wei S, Guo X, Huang Y, et al
     Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma.
     BMC Cancer. 2023;23:1247.
     PubMed     Abstract available
     
     
     
337. PARK HC, Kim H, Kim JY, Lee HY, et al
     PSMD1 as a prognostic marker and potential target in oropharyngeal cancer.
     BMC Cancer. 2023;23:1242.
     PubMed     Abstract available
     
     
     
338. DING C, Guo Y, Zhou Y, He Y, et al
     Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial).
     BMC Cancer. 2023;23:1237.
     PubMed     Abstract available
     
     
     
339. CHE J, Zhao Y, Gu B, Li S, et al
     Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with the progression of gastroesophageal cancer.
     BMC Cancer. 2023;23:1238.
     PubMed     Abstract available
     
     
     
340. WEI B, Yao J, Peng C, Zhao S, et al
     Clinical features and imaging examination assessment of cervical lymph nodes for thyroid carcinoma.
     BMC Cancer. 2023;23:1225.
     PubMed     Abstract available
     
     
     
341. ZHAO J, Zhang S, Guo X, Li C, et al
     PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis.
     BMC Cancer. 2023;23:1221.
     PubMed     Abstract available
     
     
     
342. WU S, Yuan X, Huang H, Li Y, et al
     Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma.
     BMC Cancer. 2023;23:1217.
     PubMed     Abstract available
     
     
     
343. HELENE C, Conrad O, Pflumio C, Borel C, et al
     Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE study.
     BMC Cancer. 2023;23:1209.
     PubMed     Abstract available
     
     
     
344. WANG YJ, Xie XF, He YQ, Bao T, et al
     Impact of perioperative decreased serum albumin level on anastomotic leakage in esophageal squamous cell carcinoma patients treated with neoadjuvant chemotherapy followed by minimally invasive esophagectomy.
     BMC Cancer. 2023;23:1212.
     PubMed     Abstract available
     
     
     
345. GAO J, Lan J, Liao H, Yang F, et al
     Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges.
     BMC Cancer. 2023;23:1205.
     PubMed     Abstract available
     
     
     
346. ZHENG J, Zhang H, Li S, Kang Z, et al
     Prognostic value of Hematoxylin and eosin staining tumor-infiltrating lymphocytes (H&E-TILs) in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy.
     BMC Cancer. 2023;23:1193.
     PubMed     Abstract available
     
     
     November 2023
347. LUO J, Xiao W, Hua F, Cao Y, et al
     Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: a systematic review and meta-analysis.
     BMC Cancer. 2023;23:1172.
     PubMed     Abstract available
     
     
     
348. ZHOU Q, He Q, He W, Wang C, et al
     Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study.
     BMC Cancer. 2023;23:1171.
     PubMed     Abstract available
     
     
     
349. GIOTAKIS AI, Runge A, Dudas J, Glueckert R, et al
     Analysis of cells of epithelial, connective tissue and immune differentiation in HPV-positive-, HPV-negative oropharyngeal carcinoma and normal oropharyngeal tissue by immunofluorescence multiplex image cytometry: a preliminary report.
     BMC Cancer. 2023;23:1154.
     PubMed     Abstract available
     
     
     
350. CUI L, Chen Z, Zeng F, Jiang X, et al
     Impact of sex on treatment-related adverse effects and prognosis in nasopharyngeal carcinoma.
     BMC Cancer. 2023;23:1146.
     PubMed     Abstract available
     
     
     
351. YANG Z, Zuo Q, Liu R, Wu H, et al
     Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with or without nimotuzumab in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study.
     BMC Cancer. 2023;23:1140.
     PubMed     Abstract available
     
     
     
352. CHEN C, Liu Y, Yao J, Wang K, et al
     Deep learning approaches for differentiating thyroid nodules with calcification: a two-center study.
     BMC Cancer. 2023;23:1139.
     PubMed     Abstract available
     
     
     
353. WANG H, Zhou Z, Lin W, Qian Y, et al
     MicroRNA-21 promotes head and neck squamous cell carcinoma (HNSCC) induced transition of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.
     BMC Cancer. 2023;23:1135.
     PubMed     Abstract available
     
     
     
354. ZHENG H, Yin X, Pan T, Tao X, et al
     Effect of different surgical approaches on the survival and safety of Siewert type II esophagogastric junction adenocarcinoma: a systematic review and meta-analysis.
     BMC Cancer. 2023;23:1130.
     PubMed     Abstract available
     
     
     
355. XU T, Zhu C, Song F, Zhang W, et al
     Immunological characteristics of immunogenic cell death genes and malignant progression driving roles of TLR4 in anaplastic thyroid carcinoma.
     BMC Cancer. 2023;23:1131.
     PubMed     Abstract available
     
     
     
356. HU J, Yan J, Chen Y, Li X, et al
     ESCO2 promotes hypopharyngeal carcinoma progression in a STAT1-dependent manner.
     BMC Cancer. 2023;23:1114.
     PubMed     Abstract available
     
     
     
357. SIJBEN J, Rainey L, Peters Y, Fitzgerald RC, et al
     Dutch, UK and US professionals' perceptions of screening for Barrett's esophagus and esophageal adenocarcinoma: a concept mapping study.
     BMC Cancer. 2023;23:1111.
     PubMed     Abstract available
     
     
     
358. ROUSSOT N, Fumet JD, Limagne E, Thibaudin M, et al
     A phase I study of the combination of atezolizumab, tiragolumab, and stereotactic body radiation therapy in patients with metastatic multiorgan cancer.
     BMC Cancer. 2023;23:1080.
     PubMed     Abstract available
     
     
     
359. WANG X, Yu Y, Ji Y, Ma Z, et al
     Clinical characteristics and therapeutic response of differentiated thyroid carcinoma with obesity and diabetes.
     BMC Cancer. 2023;23:1077.
     PubMed     Abstract available
     
     
     
360. YOKOTA T, Zenda S, Kodaira T, Kiyota N, et al
     Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup phase III
     BMC Cancer. 2023;23:1068.
     PubMed     Abstract available
     
     
     
361. XU X, Wang W, Tian B, Zhang X, et al
     The predicting role of serum tumor-specific growth factor for prognosis of esophageal squamous cell carcinoma.
     BMC Cancer. 2023;23:1067.
     PubMed     Abstract available
     
     
     
362. KLASEN C, Wuerdemann N, Rothbart P, Prinz J, et al
     Sex-specific aspects in patients with oropharyngeal squamous cell carcinoma: a bicentric cohort study.
     BMC Cancer. 2023;23:1054.
     PubMed     Abstract available
     
     
     
363. SUGAWARA K, Oka D, Hara H, Yoshii T, et al
     Survival outcomes of esophageal cancer patients with recurrence after curative treatments.
     BMC Cancer. 2023;23:1051.
     PubMed     Abstract available
     
     
     October 2023
364. ZHANG L, Zhou M, Gao X, Xie Y, et al
     Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity.
     BMC Cancer. 2023;23:1048.
     PubMed     Abstract available
     
     
     
365. TSUCHIHASHI K, Ito M, Arita S, Kusaba H, et al
     Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan.
     BMC Cancer. 2023;23:1046.
     PubMed     Abstract available
     
     
     
366. NATSUKI S, Tanaka H, Nishiyama M, Deguchi S, et al
     Significance of CD103(+) tissue-resident memory T cells for predicting the effectiveness of immune checkpoint inhibitors in esophageal cancer.
     BMC Cancer. 2023;23:1011.
     PubMed     Abstract available
     
     
     
367. LAU HC, Yuan X, Huang H, Zhang M, et al
     Fusobacterium nucleatum facilitates proliferation and autophagy by activating miR-361-3p/NUDT1 axis through oxidative stress in hypopharyngeal squamous cell carcinoma.
     BMC Cancer. 2023;23:990.
     PubMed     Abstract available
     
     
     
368. SHENG L, Zhuang L, Yang J, Zhang D, et al
     Radiation pneumonia predictive model for radiotherapy in esophageal carcinoma patients.
     BMC Cancer. 2023;23:988.
     PubMed     Abstract available
     
     
     
369. MODESTO A, Tougeron D, Tremolieres P, Ronchin P, et al
     Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma-randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol.
     BMC Cancer. 2023;23:966.
     PubMed     Abstract available
     
     
     
370. NIU X, Liu P, Wang X, Hu C, et al
     Is radical radiotherapy with/without surgery an effective treatment in the lymphoepithelial carcinoma of the salivary gland?.
     BMC Cancer. 2023;23:968.
     PubMed     Abstract available
     
     
     
371. ZHAO Z, Sun Y, Tang J, Yang Y, et al
     LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis, mitochondrial function in osteosarcoma and derived cancer stem-like cells.
     BMC Cancer. 2023;23:935.
     PubMed     Abstract available
     
     
     September 2023
372. SAFI S, Ahmadzade M, Karimi S, Akbari ME, et al
     A registration trend in eyelid skin cancers and associated risk factors in Iran, 2005-2016.
     BMC Cancer. 2023;23:924.
     PubMed     Abstract available
     
     
     
373. WANG M, Gao M, Chen Y, Wu J, et al
     PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling.
     BMC Cancer. 2023;23:921.
     PubMed     Abstract available
     
     
     
374. MA X, Pierce E, Anand H, Aviles N, et al
     Early prediction of response to palliative chemotherapy in patients with stage-IV gastric and esophageal cancer.
     BMC Cancer. 2023;23:910.
     PubMed     Abstract available
     
     
     
375. HUANG Q, Chen J, Huang Y, Xiong Y, et al
     The prognostic role of coagulation markers in the progression and metastasis of laryngeal squamous cell carcinoma.
     BMC Cancer. 2023;23:901.
     PubMed     Abstract available
     
     
     
376. ZHANG Y, Chen Y, Chen R, Zhou H, et al
     YTHDF3as a prognostic predictive biomarker of thyroid cancer and its correlation with immune infiltration.
     BMC Cancer. 2023;23:882.
     PubMed     Abstract available
     
     
     
377. XU S, Huang H, Dong H, Wang X, et al
     Association between surgical extent and recurrence in unilateral intermediate- to high-risk papillary thyroid cancer.
     BMC Cancer. 2023;23:880.
     PubMed     Abstract available
     
     
     
378. LI C, Guan R, Li W, Wei D, et al
     Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC.
     BMC Cancer. 2023;23:840.
     PubMed     Abstract available
     
     
     
379. DING A, Lv H, Cao J, Wang X, et al
     Ultrasonography characteristics of cystic components in primary salivary gland tumors.
     BMC Cancer. 2023;23:833.
     PubMed     Abstract available
     
     
     
380. SONG D, Ye Z, Chen F, Zhan L, et al
     circFNDC3B promotes esophageal squamous cell carcinoma progression by targeting MYO5A via miR-370-3p/miR-136-5p.
     BMC Cancer. 2023;23:821.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.